Volume 18, Number 1—January 2012
Multistate Outbreak of MDR TB Identified by Genotype Cluster Investigation
|Contacts||No. contacts, by case-patient
||Total no. contacts|
|Total no. contacts identified||3||33||10||3#||49|
|Total no. contacts evaluated||3||33||10||1||47|
|TST positive ††||3||9||8||1||21|
|Started on LTBI treatment§§||0||17||10||1||28|
*MDR TB, multidrug-resistant tuberculosis; ID, identification; AFB, acid-fast bacilli; LTBI, latent TB infection; TST, tuberculin skin test.
†Source patient. Patient had positive sputum AFB smear results, and initial chest radiograph did not show cavitary disease.
‡Patient had positive sputum AFB smear results, and initial chest radiograph showed cavitary disease.
§Patient had negative sputum AFB smear results, and initial chest radiograph did not show cavitary disease.
¶Patient had positive sputum AFB smear results, and initial chest radiograph showed cavitary disease.
#An active TB case was later identified; the patient had a matching genotype and an epidemiologic link to WA1, but this tertiary case was not identified during the secondary case-patient’s contact investigation.
**Contacts are children (CA2 and CA3) with negative culture results.
††Includes persons for whom time of conversion was not known (i.e., prior positive or new positive TST).
‡‡Defined as a positive TST following a negative TST performed in preceding 2 y.
§§Includes 2 children <5 y of age with initial negative TSTs started on “window” LTBI treatment while awaiting follow-up TST.
- Page created: December 22, 2011
- Page last updated: December 22, 2011
- Page last reviewed: December 22, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)